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Searching for somatic cells expressing the prcprocnkephalin (A) gene in the testis, we have isolated Sertoli cells from 
the testes of 20day-old rats. Cultured Sertoli cells contained a single species (about 1.5 kb) of preproenkephalin mRNA, 
and follicle-stimulating hormone (FSH) transiently increased the mRNA abundance to,a maximum (about 30 molecules 
per cell) at 12 h. Various compounds that activate the cyclic AMP system in Sertoli cells similarly increased the abundance 
of preproenkephalin mRNA. Moreover, FSH increased intracellular Met-enkephalin immunoreactive peptides in Sertoli 
cells. Thus, the preprocnkcphalin gene expression in Sertoli cells is positively regulated by FSH through the cyclic AMP 
system. 
,Preproenkephalin; mRNA; FSH; cyclic AMP; Autocrine; (Rat Sertoli cell) 
1. INTRODUCTION 
Enkephalins (Met- and Leu-enkephalin) are 
widely distributed throughout the central and 
peripheral nervous systems, and modulate various 
neuronal functions. Recent studies have shown 
that mRNA encoding preproenkephalin (A) 
(ppEnk; the precursor of Met- and Leu- 
enkephalin) is found not only in the neuronal 
tissues but also in various non-neuronal tissues 
such as the heart [ 11, lymphocytes [2], and 
reproductive systems [3]. 
In the test&, a large amount of ppEnk mRNA 
with a unique size of 1.9 kilobases (kb) is present in 
the germ cells [4,5]. Little is known, however, 
about ppEnk gene expression in testicular somatic 
(non-germinal) cells such as Leydig (i.e. 
testosterone-secreting interstitial cells), Sertoli (i.e. 
inhibin-secreting intratubular cells) and peritubular 
myoid cells. We report here that cultured rat Sertoli 
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2. MATERIALS AND METHODS 
2.1. Materials 
Rat FSH (NIH-rFSH12V07) and luteinizing hormone (NIH- 
rLH12V07) were generously provided by the National Hor- 
mone and Pituitary Program, NIDDK, NIH. Forskolin was 
donated by Nihon Kayaku Co. 8-Bromo-cyclic AMP, 
norepinephrine and dexamethasone were purchased from 
Sigma. C6 glioma cells were obtained from the American Type 
Culture Collection. 
2.2. Preparation of Sertoli cell-enriched cultures 
Sertoli cell-enriched cultures were prepared from 20-day-old 
Wistar strain rats according to Tung et al. [a]. Sertoli cells were 
plated into 100 x 20 mm tissue culture dishes (Falcon 3003) at a 
density of l-2 x lo6 aggregates. The cells were incubated at 
33°C for 4-5 days in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with antibiotics and non-essential 
amino acids under a humidified atmosphere of 95% sir/5% 
CO2, and then treated with hormones or chemicals for various 
periods of time. The culture system was verified by mor- 
phological changes of Sertoli cells in response to FSH and 
I-bromo-cyclic AMP [6]. Final cell densities were 
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l-2 x lO’/dish, and viability of the harvested Sertoli cells was 
more than 95% by trypan blue exclusion test. 
2.3. RNA extraction and blot hybridization 
Total cellular RNA was extracted from cultured Sertoli cells 
by the differential ethanol precipitation method [7], and quan- 
tified by ultraviolet absorption at 260 nm. Yields of total RNA 
were 70 * 0.8 rg/dish. ppEnk and ,&actin mRNAs were ana- 
lyzed by Northern blotting as in [8]: Total RNA was electropho- 
resed on a 6% formaldehyde/l .2% agarose gel, and blotted on- 
to a nylon membrane (Hybond-N, Amersham). RNA blots were 
hybridized with “P-labeled probes of ppEnk cDNA (pRPE2) 
[8] and Bactin DNA (a gift from Dr B. Paterson, NCI/NIH). 
Quantitative dot-blot analysis of ppEnk mRNA was performed 
using the SPdtranscribed ppEnk RNA standard [5,9]. The 
autoradiogram exposed at - 80°C with an intensifying screen 
was scanned with a densitometer (Shimadzu model CS-9000) for 
quantitation of the hybridization signals. 
2.4. Met-enkephalin radioimmunoassay 
Sertoli and C6 glioma cells were plated into 60 x 15 mm tissue 
culture dishes (Falcon 3002). Met-enkephalin (Met-enk) im- 
munoreactivity in the cell extract was determined by radioim- 
munoassay using ‘?-Met-enk (Amersham) and RB4 antiserum 
(a gift from Dr S. Sabol, NHLBWNIH) [lO,ll]. An aliquot of 
the extract was treated sequentially with trypsin and carboxy- 
peptidase B to release Met-enkephalin from the unprocessed 
precursor [10,12]. The protein content of cell lysates was deter- 
mined by bicinchoninic acid method [13] using bovine serum 
albumin as a standard. 
3. RESULTS 
Cultured Sertoli cells contained a single species 
of ppEnk mRNA of 1.5 kb length; treatment with 
FSH for 6 h at 0.3 and 1.0 pg/ml increased the 
ppEnk mRNA levels to 12- and 13-times the con- 
trol, respectively (fig.lA). The size of ppEnk 
mRNA in Sertoli cells is identical to that present in 
other ppEnk gene-expressing tissues except for 
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Fig.1. Effect of FSH on ppEnk mRNA abundance in cultured Sertoli cells. (A) Dose-response curve. Cultured Sertoli cells were in- 
cubated with various concentrations of FSH for 6 h. (B) Time course. Sertoli cells were treated with FSH (0.5 rg/ml) for various periods 
prior to harvesting. Autoradiographic densities are given in arbitrary units. Insets; autoradiograms of 6 h exposure. 
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Fig.2. Quantitative dot-blot analysis of ppEnk mRNA in Sertoli 
cells cultured in the absence or presence of FSH. Sertoli cells 
were incubated in the absence (CONT) or presence of FSH 
(FSH) at 0.5 /g/ml for 12 h. Seven known amounts of 
SP6-transcribed ppEnk RNA (STD) and of total RNA prepared 
from the Sertoli cells were hybridized with the “P-labeled 
ppEnk cDNA probe. 1 pg of the 950-base ppEnk RNA standard 
corresponds to 3.1 x lo-l8 mol. An autoradiogram of 6 h ex- 
posure is shown. Calculated values are in the text. 
ppEnk mRNA in FSH-treated cells showed an ap- 
parent peak at 12 h, and declined to near-control 
level in 48 h (fig.lB). The time course resembles 
that of the norepinephrine-induced ppEnk mRNA 
change in C6 glioma cells as reported in [9]. 
The abundances of ppEnk mRNA in control and 
FSH-stimulated Sertoli cells were quantified by 
dot-blot analysis using synthetic ppEnk RNA as a 
standard (fig.2). The ppEnk mRNA abundances in 
unstimulated (control) and maximally stimulated 
cells were 0.36 and 5.7 pg/pg total RNA, respec- 
tively, when corrected for the difference in size be- 
tween natural ppEnk mRNA (1.5 kb) and synthetic 
ppEnk RNA (0.95 kb). These correspond to 2.0 
(control) and 29.5 (FSH-stimulated) ppEnk mRNA 
molecules per cell. 
FSH exerts its effect through the receptor- 
mediated cyclic AMP system in Sertoli cells. 
Therefore, effects of various compounds that ac- 
tivate the cyclic AMP system were examined (fig.3, 
upper panel). FSH, forskolin (an adenylate cyclase 
activator), 8-bromo-cyclic AMP (a membrane- 
permeable analogue of cyclic AMP) and nor- 
epinephrine (a ,&adrenergic agonist) markedly in- 
creased the ppEnk mRNA abundance, indicating 
that FSH exerts its effect through the cyclic AMP 
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Fig.3. Effects of various compounds that activate cyclic AMP 
system on ppEnk mRNA abundance in cultured Sertoli cells. 
Sertoli cells were treated with various compounds for 7 h (B-G). 
Lanes: A, rat cerebral cortex; B, untreated control; C, FSH 
(0.5 fig/ml); D, luteinizing hormone (0.5 pg/ml); E, forskolin 
(10 PM); F, 8-bromo-cyclic AMP (0.5 mM); G, norepinephrine 
(IO/M). RNA blots were initially hybridized with the “P- 
labeled ppEnk cDNA probe, and then re-probed with 32P- 
labeleda-actin DNA after stripping ppEnk cDNA probe. Auto- 
radiograms of ppEnk mRNA and fl-actin mRNA are of 16 and 
1 h exposure, respectively. Numbers at right are the sizes of 
hybridized signals. 
(i.e. the pituitary hormone that regulates the func- 
tions of Leydig cells) caused a much smaller in- 
crease in the ppEnk mRNA level. These com- 
pounds failed to exert appreciable ffects on the fl- 
actin mRNA levels used as a control (fig.3, lower 
panel). 
To examine whether FSH-induced ppEnk 
mRNA is translatable into ppEnk that is further 
processed to enkephalins and related peptides, we 
then determined Met-enk immunoreactivity in Ser- 
toli cells. Very little Met-enk immunoreactivity was 
detected in the control (unstimulated) Sertoli cells, 
but it was markedly increased by treatment with 
FSH or forskolin (table 1). The Met-enk immuno- 
reactivity after limited proteolysis was similar to 
that before the treatment, suggesting that ppEnk is 
almost completely processed. On the other hand, 
C6 glioma cells contained some processed Met-enk, 
and limited proteolysis increased Met-enk im- 
munoreactivity 2.1- and 4.6-fold in unstimulated 
and stimulated cells, respectively (table 1). These 
results suggest hat Sertoli cells, unlike C6 cells, 
possess the machinery for processing the newly 
synthesized ppEnk (e.g. secretory granules contain- 
ing precursor-processing enzymes). 
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Table 1 
Met-enkephalin immunoreactivity in cultured Sertoli cells and 
C6 glioma cells 
Additions Protein Met-enkephalin immunoreactivity 
&g/dish) (fmol/mg protein) 
Before digestion After digestion 
Sertoli cells 
None 568 + 8 <8 <8 
FSH 75.5 f 41 sort7 58 f 5 
Forskolin 818 f 15 47 + 3 45 f 5 
C6 glioma cells 
None 1842 f 17 14* 3 30 f 4 
Forskolin 
+ Dex 1813 rf: 21 11+2 51+3 
Sertoli cells were cultured for 5 days, and treated with FSH 
(0.5 ,ug/ml) or forskolin (10 /tM) for 24 h before harvesting. C6 
glioma cells were cultured to near confluency in DMEM sup- 
plemented with 10% fetal calf serum at 37”C, and treated with 
forskolin (IOpM) plus dexamethasone (Dex) (1 PM) for 24 h 
before harvesting (final cell densities: Sertoli cells, 6 x lo6 
cells/dish; C6 g!ioma cells, 7 x lo6 cells/dish). Values are means 
f SE (n = 5) 
4. DISCUSSION 
Kilpatrick et al. [14] have reported that mouse 
testis contains a considerable amount of 1.45 kb 
ppEnk mRNA before postnatal day 16. We have 
observed a small amount of 1.5 kb ppEnk mRNA 
in rat testis before postnatal day 20 (unpublished), 
although the level was much lower than that of 
1.9 kb ppEnk mRNA in the germ cells that ap- 
peared after postnatal day 30 [5]. These findings 
suggest hat ppEnk ‘mRNA in the testis during the 
early period of postnatal development arises from 
the Sertoli cells. However, testicular somatic cells 
expressing the ppEnk gene in vivo need to be iden- 
tified by future studies (e.g. in situ hybridization 
histochemistry). 
Sertoli cells possess high-affinity opiate-binding 
sites [15], through which P-endorphin, another 
opioid peptide produced by Leydig cells, 
modulates the functions of adjacent Sertoli cells as 
a paracrine regulator [16,17]. It is tempting to 
speculate that enkephalins and related peptides 
produced by Sertoli cells also modulate the Sertoli 
cell functions as an autocrine regulator. 
Besides FSH, various neurotransmitters and hor- 
mones such as &adrenergic agonists, muscarinic 
cholinergic agonists 1181, opioid peptides [161, and 
186 
cY-melanocyte stimulating hormone [ 191 modulate 
the functions of Sertoli cells. Thus, Sertoli cells 
may represent a useful model system for studies on 
multifactorial regulation of ppEnk gene expression 
in the nervous system. 
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